赣南医学院学报
贛南醫學院學報
공남의학원학보
JOURNAL OF GANNAN MEDICAL COLLEGE
2014年
3期
391-393
,共3页
血脂康%高脂血症合并糖耐量减低%疗效
血脂康%高脂血癥閤併糖耐量減低%療效
혈지강%고지혈증합병당내량감저%료효
Xuezhikang%combined hyperlipidemia and impaired glucose tolerance%clinical effects
目的：探讨血脂康治疗高脂血症合并糖耐量减低患者的临床治疗效果。方法：选取2012年6月到2013年12月在我院就诊的高脂血症合并糖耐量减低患者74例，随机分为治疗组和对照组，每组37例。治疗组采用口服血脂康治疗；对照组给予口服烟酸缓释片治疗，两组疗程均为2个月。结果：两组患者在接受上述方案治疗前，血清总胆固醇、甘油三酯、低密度脂蛋白-胆固醇等三项血脂检测指标对比差异不明显，无统计学意义（>0.05），在接受治疗后，两组患者的上述三项检测指标均较治疗前有显著改善；两组治疗前后，疗效差异具有统计学意义，且治疗组血清总胆固醇、甘油三酯与低密度脂蛋白-胆固醇等三项指标改善情况明显优于对照组，组间对比具有统计学意义（<0.05）。治疗组总有效率和显效率要明显优于对照组，各项指标比较差异具有显著性（<0.05）。结论：利用血脂康治疗高脂血症合并糖耐量减低患者疗效显著，无不良反应，安全可靠，值得在临床中使用推广。
目的：探討血脂康治療高脂血癥閤併糖耐量減低患者的臨床治療效果。方法：選取2012年6月到2013年12月在我院就診的高脂血癥閤併糖耐量減低患者74例，隨機分為治療組和對照組，每組37例。治療組採用口服血脂康治療；對照組給予口服煙痠緩釋片治療，兩組療程均為2箇月。結果：兩組患者在接受上述方案治療前，血清總膽固醇、甘油三酯、低密度脂蛋白-膽固醇等三項血脂檢測指標對比差異不明顯，無統計學意義（>0.05），在接受治療後，兩組患者的上述三項檢測指標均較治療前有顯著改善；兩組治療前後，療效差異具有統計學意義，且治療組血清總膽固醇、甘油三酯與低密度脂蛋白-膽固醇等三項指標改善情況明顯優于對照組，組間對比具有統計學意義（<0.05）。治療組總有效率和顯效率要明顯優于對照組，各項指標比較差異具有顯著性（<0.05）。結論：利用血脂康治療高脂血癥閤併糖耐量減低患者療效顯著，無不良反應，安全可靠，值得在臨床中使用推廣。
목적：탐토혈지강치료고지혈증합병당내량감저환자적림상치료효과。방법：선취2012년6월도2013년12월재아원취진적고지혈증합병당내량감저환자74례，수궤분위치료조화대조조，매조37례。치료조채용구복혈지강치료；대조조급여구복연산완석편치료，량조료정균위2개월。결과：량조환자재접수상술방안치료전，혈청총담고순、감유삼지、저밀도지단백-담고순등삼항혈지검측지표대비차이불명현，무통계학의의（>0.05），재접수치료후，량조환자적상술삼항검측지표균교치료전유현저개선；량조치료전후，료효차이구유통계학의의，차치료조혈청총담고순、감유삼지여저밀도지단백-담고순등삼항지표개선정황명현우우대조조，조간대비구유통계학의의（<0.05）。치료조총유효솔화현효솔요명현우우대조조，각항지표비교차이구유현저성（<0.05）。결론：이용혈지강치료고지혈증합병당내량감저환자료효현저，무불량반응，안전가고，치득재림상중사용추엄。
Objectiye:To explore the therapeutic effect of Xuezhikang in treating patients with combined hyperlipidemia and impaired glucose tolerance. Methods:74 cases with combined hyperlipidemia and impaired glucose tolerance treated in our hospital from June,2012 to December,2013 were selected. They were randomly divided into treatment group and control group,37 cases in each group. In the treatment group,Xuezhikang was taken orally;in control group,Nicotinic Acid Sustained Release Tablets were taken orally,a course of the two groups was 2 months. Results:Before applying the a-bove treatments,the differences of testing index of total serum cholesterol,triglyceride,low density lipoprotein cholesterol (hdl-c)and other three lipid testing index were not obvious,no statistical significance( > 0. 05). After treatment,the three testing indexes were greatly improved. In the two groups before and after treatment,the curative effect difference is statistically significant. In the treatment group,the improvement was better than the control group,with statistical signifi-cance( < 0. 05). The total effectiveness and significant efficiency was much better than that of the control group with significant differences( < 0. 05). Conclusion:Xuezhikang in treating patients with combined hyperlipidemia and im-paired glucose tolerance is with obvious therapeutic effect,no adverse reaction,safe and reliable,and worth popularizing in clinical application.
